Takeda Pharmaceutical (TAK) Gross Profit (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Gross Profit of $5.1 billion for Q2 2026, down 5.56% year-over-year from $5.4 billion in Q2 2025, and down 1.61% quarter-over-quarter from $5.2 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Gross Profit (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Gross Profit history runs 10 years deep, the most recent figure standing at $5.1 billion for Q2 2026.
- In Q2 2026, Gross Profit fell 5.56% year-over-year to $5.1 billion; the TTM figure through Jun 2026 stood at $30.6 billion (down 0.79% YoY), while the FY2026 annual figure was $5.4 billion, changed 0.23% from the prior year.
- Gross Profit for Q2 2026 stood at $5.1 billion, down from $5.2 billion in the prior quarter.
- The five-year high for Gross Profit was $15.8 billion in Q3 2025, with the low at $4.4 billion in Q4 2024.
- The 5-year median for Gross Profit is $5.4 billion (2022), against an average of $7.4 billion.
- Peak annual rise in Gross Profit reached 199.34% in 2022, while the deepest fall reached 16.72% in 2022.
- Takeda Pharmaceutical's Gross Profit stood at $4.6 billion in 2022, then retreated by 1.17% to $4.5 billion in 2023, then declined by 2.35% to $4.4 billion in 2024, then rose by 1.36% to $4.5 billion in 2025, then advanced by 13.99% to $5.1 billion in 2026.
- Business Quant data shows TAK's Gross Profit at $5.1 billion in Q2 2026, $5.2 billion in Q1 2026, and $4.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10 Bn |
| Jun 30, 2026 | 5.10 Bn |
| Mar 31, 2026 | 5.19 Bn |
| Mar 31, 2026 | 5.19 Bn |
| Dec 31, 2025 | 4.48 Bn |
| Dec 31, 2025 | 4.48 Bn |
| Sep 30, 2025 | 15.81 Bn |
| Sep 30, 2025 | 15.81 Bn |
| Jun 30, 2025 | 5.40 Bn |
| Jun 30, 2025 | 5.40 Bn |
| Mar 31, 2025 | 5.38 Bn |
| Mar 31, 2025 | 5.38 Bn |
| Dec 31, 2024 | 4.42 Bn |
| Dec 31, 2024 | 4.42 Bn |
| Sep 30, 2024 | 15.62 Bn |
| Sep 30, 2024 | 15.62 Bn |
| Jun 30, 2024 | 5.02 Bn |
| Jun 30, 2024 | 5.02 Bn |
| Mar 31, 2024 | 5.54 Bn |
| Mar 31, 2024 | 5.54 Bn |